UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009698 |
|---|---|
| Receipt number | R000011370 |
| Scientific Title | Phase II crinical trial of cetuximab rechallenge with KRAS wild-type unresectable/recurrent colorectal cancer |
| Date of disclosure of the study information | 2013/01/07 |
| Last modified on | 2018/06/25 14:56:14 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/01/05 13:16:54 | ||
| 2 | Update | 2013/01/05 14:01:51 | Institute Institute |
|
| 3 | Update | 2013/01/05 14:06:41 | Institute Institute |
|
| 4 | Update | 2013/01/06 05:38:12 | Anticipated trial start date |
|
| 5 | Update | 2013/01/06 05:39:44 | Date of disclosure of the study information |
|
| 6 | Update | 2013/06/13 14:24:16 | Key inclusion criteria |
|
| 7 | Update | 2018/06/25 14:56:14 | Recruitment status |
